Completed NA INTERVENTIONAL 1-arm NCT03368261

Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe. (SAPOTILLE)

Epidemiology and Pathophysiological Mechanisms of Pulmonary Arterial Hypertension in SS and SC Children in Martinique and Guadeloupe.Three Years Follow up of a Cohort of Children Aged From 8 to 16 Years Old

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe

Conditions Sickle Cell Disease

Interventions HTAP/ clinical complications in the sickle cell disease

Updated 6 times since 2017 Last updated: Dec 5, 2017 Started: Jan 11, 2010 Primary completion: Oct 2, 2013 Completion: Oct 17, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03368261, this NA trial focuses on Sickle Cell Disease and remains completed. Sponsored by Centre Hospitalier Universitaire de la Guadeloupe, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Mar 2025 — Present [monthly]

Completed NA
Sep 2024 — Mar 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de la Guadeloupe

Data source: Centre Hospitalier Universitaire de la Guadeloupe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort-de-France, Martinique